Loading...
Using Real-World Data to Rationalize Clinical Trials Eligibility Criteria Design: A Case Study of Alzheimer’s Disease Trials
Low trial generalizability is a concern. The Food and Drug Administration had guidance on broadening trial eligibility criteria to enroll underrepresented populations. However, investigators are hesitant to do so because of concerns over patient safety. There is a lack of methods to rationalize crit...
Na minha lista:
| Udgivet i: | AMIA Annu Symp Proc |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Medical Informatics Association
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8075542/ https://ncbi.nlm.nih.gov/pubmed/33936446 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|